Ignite Creation Date:
2025-12-25 @ 1:38 AM
Ignite Modification Date:
2025-12-31 @ 9:52 PM
Study NCT ID:
NCT01370694
Status:
TERMINATED
Last Update Posted:
2019-03-15
First Post:
2011-05-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of MK-8808 for Participants With Follicular Lymphoma (MK-8808-001)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-08-19
Start Date Type:
ACTUAL
Primary Completion Date:
2014-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-12-01
Completion Date Type:
ACTUAL
First Submit Date:
2011-05-18
First Submit QC Date:
None
Study First Post Date:
2011-06-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-10-23
Results First Submit QC Date:
None
Results First Post Date:
2015-11-25
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-02-28
Last Update Post Date:
2019-03-15
Last Update Post Date Type:
ACTUAL